Cefotaxime bulk supplier for pharma manufacturers

Cefotaxime 250 mg, 500 mg, 1 g, 2 g Suppliers & Bulk Manufacturers

Available Forms: IV and IM Injection

Available Strengths: 250 mg, 500 mg, 1 g, 2 g

Reference Brands: Claforan(US)

Cefotaxime is a third-generation cephalosporin antibiotic used to treat severe infections like pneumonia and sepsis. Available in 250 mg to 2 g IV/IM vials, it is supplied under brands like Claforan and by major generics. Pharma B2B platforms offer bulk sourcing for hospitals and emergency care providers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Cefotaxime is a third-generation cephalosporin antibiotic used for the treatment of severe bacterial infections such as pneumonia, sepsis, meningitis, and urinary tract infections. Administered via intravenous (IV) or intramuscular (IM) injection, it is available as a lyophilized powder in 250 mg, 500 mg, 1 g, and 2 g vials. In the US, Cefotaxime was initially marketed as Claforan by Sanofi and is now widely available as a generic from Hikma, Sagent, and others. In the EU, leading suppliers include Fresenius Kabi, Sandoz, and Mylan. Pharma B2B platforms enable efficient sourcing of bulk Cefotaxime for hospitals and critical care centers.

Cefotaxime — third party manufacturing & bulk supply

Cefotaxime 250 mg, 500 mg, 1 g, 2 g is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cefotaxime is supplied as IV and IM Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cefotaxime listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cefotaxime →

Back to Listing

Frequently Asked Questions

Cefotaxime is listed as IV and IM Injection in 250 mg, 500 mg, 1 g, 2 g. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cefotaxime is referenced against Claforan(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.